CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV and HCV), performed on the Tigris testing platform, to the -enhanced Ultrio Elite triplex assay performed on the Panther testing platform on July 13, 2020. The implementation date has been moved up to July 7th. Contact your Customer Service Manager if you have any questions!
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...
On June 13, 2019, the new CTS Laboratory Information System was successfully implemented in Cha...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
CTS communications distributed on July 6th and July 20th.In working with Grifols on the availability...